Scarica l'app Stockscreener
2.21
3.28%
-0.075
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.285
Aprire:
$2.2447
Volume 24 ore:
15,882
Relative Volume:
0.52
Capitalizzazione di mercato:
$23.72M
Reddito:
$56.60M
Utile/perdita netta:
$-34.12M
Rapporto P/E:
-0.4821
EPS:
-4.5844
Flusso di cassa netto:
$-1.36M
1 W Prestazione:
-1.78%
1M Prestazione:
+0.00%
6M Prestazione:
-15.16%
1 anno Prestazione:
-2.21%
Intervallo 1D:
$2.185
$2.39
Intervallo di 1 settimana:
$2.185
$2.39
Portata 52W:
$1.6501
$3.065
Aytu Biopharma Inc Stock (AYTU) Company Profile
Nome
Aytu Biopharma Inc
Settore
Telefono
(720) 437-6580
Indirizzo
7900 E. UNION AVENUE, DENVER
Compare AYTU vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.21 | 24.47M | 56.60M | -34.12M | -1.36M | -4.5844 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Lake Street | Buy |
| 2025-06-30 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Iniziato | H.C. Wainwright | Buy |
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Aytu (AYTU) Q2 2026 Earnings: EPS Misses Its Estimate; Closing Move: The Market Reaction Is Muted in the Current UpdatePerformance Review - vinanet.vn
Aytu BioPharma (AYTU) investor and foundation each report 4.99% beneficial stake - Stock Titan
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
Aytu BioPharma (AYTU) Slips 1.7% to $2.36 as Biotech Volatility PersistsRisk Parity Rebalance - vinanet.vn
Aytu Biopharma Inc (AYTU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AYTU Q2 2026 Earnings: Narrow EPS Miss Slightly Wider Than Expected, Shares Rise 1.69%Earnings Expansion Phase - vinanet.vn
Aytu Biopharma Inc (AYTU) Stock News Today - TradingKey
Aytu BioPharma, Inc. (0A8M.L) valuation measures and financial statistics - Yahoo Finance Australia
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Aytu BioPharma (AYTU) Climbs 3.72% to $2.23 — Approaching Key ResistanceBreadth Thrust - vinanet.vn
Aytu BioScience Inc (0A8M) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Aytu Biopharma Inc (AYTU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aytu Biopharma Inc (AYTU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aytu BioPharma Market Sentiment - Benzinga España
Aytu Biopharma Inc (AYTU) Cash Flow - TradingKey
Aytu Biopharma Inc (AYTU) Balance Sheet - TradingKey
AYTU|Aytu Biopharma Inc|Price:2.107|Chg%:+0.046 - TradingKey
AYTU|Aytu Biopharma Inc|Price:2.160| - TradingKey
Aytu Biopharma Inc (AYTU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aytu Biopharma Inc (AYTU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aytu Biopharma Inc (AYTU) Income Statement - TradingKey
AYTU Q2 2026 Earnings: EPS Misses Estimates by Nearly 2%, Stock Holds SteadyProfit Announcement - vinanet.vn
Aytu BioPharma, Inc. Revenue Breakdown – NASDAQ:AYTU - TradingView
AYTU Q2 2026 Earnings: EPS Slightly Misses Estimates with Minimal SurprisePerformance Review - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterCore Business Growth - vinanet.vn
Aytu BioPharma (AYTU) Edges Higher as Stock Tests Key ResistanceOvernight Profile - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid No Revenue; Stock Edges HigherCapex Guidance - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Consensus, Stock Falls SlightlyRevenue Guidance Update - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates, Stock DeclinesNet Income Trends - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates, Shares Edge HigherPost-Earnings Drift - Vinanet
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid Narrow Loss; Stock Edges HigherPost-Earnings Drift - vinanet.vn
Aytu BioPharma (AYTU) Edges Higher, Testing Key Resistance LevelsGap Fill Strategy - dars.gov.et
AYTU Q2 2026 Earnings: EPS Miss Slightly Wider Than Expected; Stock Rises 2.74% Amid Strategic ReviewEarnings Beat Streak - dars.gov.et
AYTU Q2 2026 Earnings: EPS Misses Estimates Slightly, Stock Edges HigherNet Profit Margin - dars.gov.et
Aytu BioPharma Holds Steady Near $2.16 Amid Modest Gains – Key Levels in FocusFactor Valuation - DonanımHaber
Aytu BioPharma | SCHEDULE 13G/A: Others - Moomoo
Aytu BioPharma, Inc. (AYTU) reports Q3 loss, tops revenue estimates - MSN
Aytu BioPharma, Inc. Actuals & Estimates (NASDAQ:AYTU) - TradingView
AYTU Forecast — Price Target — Prediction for 2027 - TradingView
Aytu BioPharma, Inc. Actuals & Estimates (LSE:0A8M) - TradingView
0A8M Forecast — Price Target — Prediction for 2027 - TradingView
Aytu Biopharmato Continue Selling Existing - Moomoo
Aytu BioPharma Ends Metadate CD License With Lannett; Sell-Through Allowed After Mutual Termination - TradingView
Aytu BioPharma (AYTU) ends Metadate CD license agreement with Lannett - Stock Titan
Price to sales forward of Aytu BioPharma, Inc. – NASDAQ:AYTU - TradingView
Enterprise value to EBIT forward of Aytu BioPharma, Inc. – NASDAQ:AYTU - TradingView
Enterprise value to revenue forward of Aytu BioPharma, Inc. – NASDAQ:AYTU - TradingView
AYTU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aytu Biopharma Inc (AYTU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aytu BioPharma Surges 9.7%: Key Levels and Potential Catalysts for AYTU StockDark Pool Sentiment - dars.gov.et
Aytu Biopharma Inc (AYTU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.66%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):